MedPath

TEVA-NABUMETONE

TEVA-NABUMETONE

Discontinued
DIN Number

02240868

Drug Class

Human

Market Date

May 18, 2000

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240868
AIG Number0122821002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NABUMETONEActive
Strength: 750 MG
Monograph: NABUMETONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.